Summary: Bunge Global has underperformed the broader S&P 500 Index over the past year, and analysts remain moderately bullish on the stock’s prospects.
Chesterfield, Missouri-based Bunge Global SA (BG) operates as an agribusiness and food company worldwide. With a market cap of $11.5 billion, the company operates through four segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy.
Companies worth $10 billion or more are typically referred to as "large-cap stocks." BG fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the farm products industry. Its competitive strengths lie in its expansive and integrated global supply chain, diversified operations across agribusiness, food ingredients, and edible oils, and its strategic focus on growth through acquisitions and partnerships. The company’s emphasis on operational efficiency, digitalization, and cost control enhances its margin performance, while its leadership in sustainable sourcing and traceability reinforces its position with major global food and energy players.
Despite its strengths, the stock has dipped 25.7% from its 52-week high of $114.92 touched on Jul. 26, 2024. Moreover, over the past three months, BG stock has surged 15.5%, outperforming the S&P 500 Index’s ($SPX) 5.4% uptick during the same time frame.
BG stock has grown 9.8% on a YTD basis, outperforming SPX’s 1.5% uptick in 2025. However, BG has declined 17.4% over the past 52 weeks, underperforming SPX’s 9% gains.
To confirm its recent uptrend, BG stock has been trading above its 200-day and 50-day moving averages since mid-June.
BG stock dropped 2.9% following the release of its Q1 results on May 7. The company’s net sales declined 13.2% year-over-year to $11.6 billion, missing the Street’s expectations by a large margin. Moreover, its adjusted net income decreased 44.7% year-over-year to $244 million. However, BG’s adjusted EPS for the quarter came in at $1.81, which surpassed the consensus estimates by 42.5%.
Within the farm products arena, rival Tyson Foods, Inc. (TSN) has declined 5.3% in 2025 and 3.1% over the past year, outperforming the stock.
Among the seven analysts covering the BG stock, the consensus rating is a “Moderate Buy.” Its mean price target of $85.88 suggests a marginal upside potential from current price levels.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
